当前位置:首页 - 行情中心 - 三元生物(301206) - 财务分析 - 现金流量表

三元生物

(301206)

  

流通市值:35.11亿  总市值:54.53亿
流通股本:1.30亿   总股本:2.02亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金214,238,273.18711,077,821.77544,775,312.94369,921,011.53
  收到的税费返还13,645,722.849,037,630.4934,528,768.826,525,937.72
  收到其他与经营活动有关的现金3,009,395.357,558,470.6111,245,269.714,852,660.12
  经营活动现金流入小计230,893,391.33767,673,922.87590,549,351.45401,299,609.37
  购买商品、接受劳务支付的现金134,746,443.14646,245,659.32468,868,978.81338,994,006.24
  支付给职工以及为职工支付的现金16,779,668.8155,513,324.9641,365,165.529,056,758.23
  支付的各项税费2,789,017.1729,415,770.5243,395,785.0922,289,607.37
  支付其他与经营活动有关的现金14,256,813.9413,683,431.0511,816,941.429,036,784.88
  经营活动现金流出小计168,571,943.06744,858,185.85565,446,870.82399,377,156.72
  经营活动产生的现金流量净额62,321,448.2722,815,737.0225,102,480.631,922,452.65
二、投资活动产生的现金流量:
  收回投资收到的现金3,040,000,0008,896,799,0008,363,400,0007,890,100,000
  取得投资收益收到的现金36,297,674.86294,941,867.34293,654,242.99292,042,664.91
  处置固定资产、无形资产和其他长期资产收回的现金净额-99,83563,6353,635
  收到的其他与投资活动有关的现金-9,440,0009,440,0005,460,000
  投资活动现金流入小计3,076,297,674.869,201,280,702.348,666,557,877.998,187,606,299.91
  购建固定资产、无形资产和其他长期资产支付的现金39,674,025.22199,145,003.39139,696,433.7109,780,064.24
  投资支付的现金3,165,026,408.238,457,799,0008,152,400,0007,706,800,000
  支付其他与投资活动有关的现金-9,490,0009,150,0005,160,000
  投资活动现金流出小计3,204,700,433.458,666,434,003.398,301,246,433.77,821,740,064.24
  投资活动产生的现金流量净额-128,402,758.59534,846,698.95365,311,444.29365,866,235.67
三、筹资活动产生的现金流量:
  吸收投资收到的现金-400,000-400,000
  收到其他与筹资活动有关的现金-3,000,0002,000,0002,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-3,400,0002,000,0002,400,000
  分配股利、利润或偿付利息支付的现金-348,646,923.76239,296,365.31239,296,365.31
  支付其他与筹资活动有关的现金-46,485,550.5645,491,454.445,091,550.56
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-395,132,474.32284,787,819.71284,387,915.87
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--391,732,474.32-282,787,819.71-281,987,915.87
四、汇率变动对现金及现金等价物的影响-1,258,762.9-1,286,823.88-754,789.21164,489.37
五、现金及现金等价物净增加额-67,340,073.22164,643,137.77106,871,31685,965,261.82
  加:期初现金及现金等价物余额324,935,490.8160,292,353.03160,292,353.03160,292,353.03
  期末现金及现金等价物余额257,595,417.58324,935,490.8267,163,669.03246,257,614.85
补充资料:
  净利润-91,296,559.96-57,367,849.85
  资产减值准备-272,312.9--
  固定资产和投资性房地产折旧-72,193,447.79-35,910,478.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-72,193,447.79-35,910,478.45
  无形资产摊销-1,341,332.52-545,791.26
  处置固定资产、无形资产和其他长期资产的损失--65,753.16-36,368.8
  公允价值变动损失--367,116.65--
  投资损失--69,511,758.02--36,233,619.1
  递延所得税--7,575,744.44--11,229,942.75
    递延所得税负债增加--7,575,744.44--11,229,942.75
  存货的减少--32,146,961.88--48,655,213.17
  经营性应收项目的减少-40,432,240.35-52,316,936.62
  经营性应付项目的增加--72,883,974.2--48,300,570.23
  现金的期末余额-324,935,490.8-246,257,614.85
  减:现金的期初余额-160,292,353.03-160,292,353.03
  现金及现金等价物的净增加额-164,643,137.77-85,965,261.82
公告日期2026-04-292026-04-292025-10-272025-08-29
审计意见(境内)标准无保留意见
TOP↑